372
Participants
Start Date
March 31, 2024
Primary Completion Date
September 30, 2027
Study Completion Date
September 30, 2027
High dose rifampicin (25mg/kg)
Given for 2 months
Moxifloxacin 400mg
Given for 2 months
Aspirin 150 mg
Given for 2 months
Isoniazid
Given for 6 months
Pyrazinamide
Given for 6 months
Steroid
Tapering dose of dexamethasone or prednisolone upto 8 weeks
Rifampicin
Standard dose for 4 months after the initial treatment with high dose
HRZE
2 months
HRE
7-10 months as per TB program guidelines
ICMR- National Institute for Research in Tuberculosis, Chennai
Collaborators (1)
All India Institute of Medical Sciences, Jodhpur
OTHER_GOV
Christian Medical College, Vellore, India
OTHER
Jawaharlal Institute of Postgraduate Medical Education & Research
OTHER_GOV
North Eastern Indira Gandhi Regional Institute of Health ans Medical Sciences
OTHER_GOV
Madras Medical College
OTHER_GOV
Rural Development Trust Hospital
OTHER
Indian Council of Medical Research
OTHER_GOV